MRNA US60770K1079

Report

Delayed Nasdaq - 10/25 04:00:00 pm
349.56	USD		+7.05%

05:58p	MODERNA : U.S. administers 414.3 mln doses of COVID-19 vaccines - CDC	RE
05:28p	MODERNA : U.S. CDC Says Delivered 503,418,475 Doses Of Covid-19 Vaccine As Of Oct 25	RE
05:05p	MODERNA : European Medicines Agency Panel Recommends Booster Shots for Moderna's COVID-19 Vaccine	MT

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq

10/19/2021	10/20/2021	10/21/2021	10/22/2021	10/25/2021	Date
333.61(c)	333.01(c)	339.57(c)	326.54(c)	349.56	Last
8 561 130	4 983 222	5 597 599	7 780 241	9 772 171	Volume
-0.37%	-0.18%	+1.97%	-3.84%	+7.05%	Change

More quotes

Estimated financial data (e) (USD)

Sales 2021	20 374 M - -
Net income 2021	12 558 M - -
Net cash position 2021	13 559 M - -
P/E ratio 2021	11,7x
Yield 2021	-

Sales 2022	20 718 M - -
Net income 2022	10 722 M - -
Net cash position 2022	26 152 M - -
P/E ratio 2022	14,1x
Yield 2022	-

Capitalization	141 B 141 B -
EV / Sales 2021	6,26x
EV / Sales 2022	5,55x
Nbr of Employees	1 300
Free-Float	90,3%

More Financials

Company

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows: - Collaboration revenue (79.8%); - Grant revenue (20.2%). At the end of 2019, the group possessed a portfolio of 6 development candidates in clinical studies, with three in phase II and...

Sector

Biotechnology & Medical Research

Calendar

11/04

Earnings Release

More about the company

Ratings of Moderna, Inc.

Trading Rating :

Investor Rating :

ESG Refinitiv :

C+

More Ratings

All news about MODERNA, INC.

05:58p	MODERNA : U.S. administers 414.3 mln doses of COVID-19 vaccines - CDC	RE
05:28p	MODERNA : U.S. CDC Says Delivered 503,418,475 Doses Of Covid-19 Vaccine As Of Oct 25	RE
05:05p	MODERNA : European Medicines Agency Panel Recommends Booster Shots for Moderna's COVID-19 ..	MT
04:53p	MODERNA : Announces European Medicines Agency's Committee for Medicinal Products for Human..	BU
04:25p	Tesla, Moderna rise; Kimberly-Clark, Restaurant Brands fall	AQ
01:47p	MODERNA : EU drug regulator OKs booster doses of Moderna's COVID shot	AQ
01:14p	MODERNA : EMA backs use of Moderna's COVID-19 booster vaccine	RE
01:09p	PFIZER : Moderna says studies show COVID-19 vaccine safe, effective in children 6-11	AQ
01:06p	MODERNA : EMA backs use of Moderna's COVID-19 booster vaccine	RE
11:31a	PFIZER : Moderna says its low-dose COVID shot works for kids 6 to 11	AQ
11:28a	Moderna Shares Higher After Interim Data for Covid-19 Vaccine in Children	DJ
10:43a	Pfizer, Moderna and J&J Booster Shots Now Available at Walmart and Sam's Club Pharmacie..	AQ
10:43a	MODERNA : Hy-Vee Now Offering Free Moderna and Janssen (J&J) COVID-19 Booster Vaccines to ..	AQ
10:43a	MODERNA : Walgreens Now Offering Moderna and Johnson & Johnson COVID-19 Vaccine Booster Sh..	AQ
09:33a	INSIDER SELL : Moderna	MT

More news

News in other languages on MODERNA, INC.

05:18p	WALL STREET : 2 records absolu, Tesla au-delà des 1.000Mds$
05:05p	Le panel de l'Agence européenne des médicaments recommande des injections de rappel pou..
04:24p	MÄRKTE USA/Neue Rekorde - Tesla-Marktkapitalisierung über 1 Billion USD
02:49p	USA-Reisen ab November möglich nach Impfung mit anerkannten Stoffen
02:44p	CORONA-BLOG/EMA lässt Moderna-Auffrischungsimpfung für über 18-Jährige zu

More news

Analyst Recommendations on MODERNA, INC.

10/22	MODERNA : Deutsche Bank Starts Moderna at Sell with $250 Price Target	MT
10/15	ANALYST RECOMMENDATIONS : BP, Domino's Pizza, Moderna, Tesla, US Bancorp...
10/15	MODERNA : Piper Sandler Upgrades Moderna to Overweight From Neutral	MT

More recommendations

Stock Trading Strategies

	MODERNA, INC. - 2020
The beginning of the move

BUY

More Stock Trading Analysis

Provided by Scoopnest.com

Analysis

Moderna : Wall St ends up with Goldman; Dow posts biggest weekly rise since June